Cite
Wang L, Rosé CD, Foley KP, et al. S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome. Rheumatology (Oxford). 2018;57(7):1299-1304doi: 10.1093/rheumatology/key090.
Wang, L., Rosé, C. D., Foley, K. P., Anton, J., Bader-Meunier, B., Brissaud, P., Chédeville, G., Cimaz, R., Fernández-Martín, J., Guly, C., Hachulla, E., Harjacek, M., Mackensen, F., Merino, R., Modesto, C., Naranjo Hernández, A., Pajot, C., Ramanan, A. V., Thatayatikom, A., Thomée, C., Vastert, S., Votta, B. J., Bertin, J., & Wouters, C. H. (2018). S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome. Rheumatology (Oxford, England), 57(7), 1299-1304. https://doi.org/10.1093/rheumatology/key090
Wang, Lin, et al. "S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome." Rheumatology (Oxford, England) vol. 57,7 (2018): 1299-1304. doi: https://doi.org/10.1093/rheumatology/key090
Wang L, Rosé CD, Foley KP, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Fernández-Martín J, Guly C, Hachulla E, Harjacek M, Mackensen F, Merino R, Modesto C, Naranjo Hernández A, Pajot C, Ramanan AV, Thatayatikom A, Thomée C, Vastert S, Votta BJ, Bertin J, Wouters CH. S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome. Rheumatology (Oxford). 2018 Jul 01;57(7):1299-1304. doi: 10.1093/rheumatology/key090. PMID: 29635517.
Copy
Download .nbib